466 related articles for article (PubMed ID: 34490899)
1. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
2. Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.
Rodrigues V; Landi F; Castro S; Mast R; Rodríguez N; Gantxegi A; Pradell J; López-Cano M; Armengol M
J Gastrointest Surg; 2021 Jun; 25(6):1388-1403. PubMed ID: 32661833
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer: Analysis from a Large-Scale Cohort.
Zhuang CL; Huang DD; Pang WY; Zhou CJ; Wang SL; Lou N; Ma LL; Yu Z; Shen X
Medicine (Baltimore); 2016 Mar; 95(13):e3164. PubMed ID: 27043677
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia assessed with DXA and CT increases the risk of perioperative complications in patients with gastrectomy.
Kim M; Lee CM; Kang BK; Ha TK; Choi YY; Lee SJ
Eur Radiol; 2023 Jul; 33(7):5150-5158. PubMed ID: 36637463
[TBL] [Abstract][Full Text] [Related]
5. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy.
Li Y; Wang WB; Yang L; Wang QY; Dai J; Xia L; Peng J; Zhou FX; Wei YC; Shi HP
Nutrition; 2022 Jan; 93():111464. PubMed ID: 34678715
[TBL] [Abstract][Full Text] [Related]
6. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
[TBL] [Abstract][Full Text] [Related]
8. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
9. Impact of Sarcopenic Obesity on Long-Term Cancer Outcomes and Postoperative Complications After Gastrectomy for Gastric Cancer.
Juez LD; Priego P; Bajawi M; Cuadrado M; Blázquez LA; Sánchez-Picot S; Galindo J; Blázquez J; Fernández-Cebrián JM; Botella-Carretero JI
J Gastrointest Surg; 2023 Jan; 27(1):35-46. PubMed ID: 36324039
[TBL] [Abstract][Full Text] [Related]
10. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis.
Lee JK; Park YS; Lee K; Youn SI; Won Y; Min SH; Ahn SH; Park DJ; Kim HH
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1897-1907. PubMed ID: 34533290
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.
Zhang Y; Wang JP; Wang XL; Tian H; Gao TT; Tang LM; Tian F; Wang JW; Zheng HJ; Zhang L; Gao XJ; Li GL; Wang XY
Curr Oncol; 2018 Oct; 25(5):e411-e422. PubMed ID: 30464692
[TBL] [Abstract][Full Text] [Related]
13. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
Şahin MEH; Akbaş F; Yardimci AH; Şahin E
BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia is an effective prognostic indicator of postoperative outcomes in laparoscopic-assisted gastrectomy.
Chen XY; Li B; Ma BW; Zhang XZ; Chen WZ; Lu LS; Shen X; Zhuang CL; Yu Z
Eur J Surg Oncol; 2019 Jun; 45(6):1092-1098. PubMed ID: 30853168
[TBL] [Abstract][Full Text] [Related]
15. The use of computed tomography images as a prognostic marker in critically ill cancer patients.
Toledo DO; Carvalho AM; Oliveira AMRR; Toloi JM; Silva AC; Francisco de Mattos Farah J; Prado CM; Silva JM
Clin Nutr ESPEN; 2018 Jun; 25():114-120. PubMed ID: 29779805
[TBL] [Abstract][Full Text] [Related]
16. EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study.
Zhuang CL; Shen X; Zou HB; Dong QT; Cai HY; Chen XL; Yu Z; Wang SL
Clin Nutr; 2020 Jul; 39(7):2301-2310. PubMed ID: 31732287
[TBL] [Abstract][Full Text] [Related]
17. CT assessment of preoperative nutritional status in gastric cancer: severe low skeletal muscle mass and obesity-related low skeletal muscle mass are unfavorable factors of postoperative complications.
Fang Z; Du F; Shang L; Liu J; Ren F; Liu Y; Wu H; Liu Y; Li P; Li L
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):317-324. PubMed ID: 33063547
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Fat Mass and Skeletal Muscle Mass Determined by Computed Tomography in Patients Who Underwent Transcatheter Aortic Valve Implantation.
Mok M; Allende R; Leipsic J; Altisent OA; Del Trigo M; Campelo-Parada F; DeLarochellière R; Dumont E; Doyle D; Côté M; Freeman M; Webb J; Rodés-Cabau J
Am J Cardiol; 2016 Mar; 117(5):828-33. PubMed ID: 26754122
[TBL] [Abstract][Full Text] [Related]
20. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
Rinninella E; Cintoni M; Raoul P; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
Clin Nutr; 2020 Jul; 39(7):2045-2054. PubMed ID: 31718876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
